Last Updated on August 20, 2021 by The Health Master
The US Food and Drug Administration (USFDA) officials visited the Gujarat Food and Drug Control Administration (FDCA) to attend regulatory forum meeting for information sharing and capacity building to tackle C-19 pandemic.
USFDA-Gujarat FDCA Regulatory Forum was started in the year 2008 to usher in dialogue between senior leaderships of the USFDA and the Gujarat FDCA for future strategic collaborations and knowledge sharing on drug and medical device compliance.
Dr Sarah McMullen, India Office, Country Director, USFDA; Christopher Priddy, JD – International Relations Specialist; Sudheendra Kulkarni (Medical Product Safety Coordinator), USFDA India; and Dhruv Shah, Medical Product Safety Coordinator, USFDA participated the meeting.
Prior to this meet, a web meet was done due to prevailing C-19 pandemic situation in the country.
“This was Dr Sarah’s first visit to Gujarat after she was appointed as country director, USFDA India office. She is the fifth Country director of India to visit Gujarat FDCA. The first was Bruce Ross who visited in the year 2010. Bruce Ross manages oversees foreign offices of FDA,” stated Gujarat FDCA Commissioner Dr H G Koshia.
In the past, a team of USFDA imparted training to all the FDCA-Gujarat officers on various technical aspects of the inspection.
The United States Food and Drug Administration is responsible for protecting and promoting public health through the control and supervision of food safety, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, and veterinary products.
Gujarat FDCA makes optimum use of information technology for achieving excellence in performance. FDCA, Gujarat is the first state to initiate online software for sales and manufacturing licenses.